Management of large hepatocellular carcinoma by sequential transarterial chemoembolization and portal vein embolization: a systematic review of the literature.

Date publication

juin 2016

Journal

Minerva chirurgica

Auteurs

Membres identifiés du Cancéropôle Est :
Pr BAUMERT Thomas , Dr HABERSETZER François , Pr PESSAUX Patrick

Tous les auteurs :
Piardi T, Memeo R, Renard Y, Ammendola M, Bruno O, Habersetzer F, Baumert T, Pessaux P, Sommacale D

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/26883849

Résumé

Currently, the treatment of HCC is multidisciplinary. Surgery remains the gold standard although the management of large hepatocellular carcinoma remains challenging. Hepatic resection is increasingly performed with ever-expanding indications. However, postoperative liver failure remains a major cause of death after major hepatic resections. The purpose of this review is to report the results of large hepatocellular carcinoma (>5 cm or more nodules in the same lobe) management using sequential transarterial chemoembolization (TACE) and portal vein embolization (PVE) before major liver resections.

Référence

Minerva Chir. 2016 Jun;71(3):192-200